Harbour Investments, Inc. Harrow Health, Inc. Transaction History
Harbour Investments, Inc.
- $2.82 Billion
- Q2 2024
A detailed history of Harbour Investments, Inc. transactions in Harrow Health, Inc. stock. As of the latest transaction made, Harbour Investments, Inc. holds 7,645 shares of HROW stock, worth $346,547. This represents 0.01% of its overall portfolio holdings.
Number of Shares
7,645
Previous 7,645
-0.0%
Holding current value
$346,547
Previous $101,000
57.43%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding HROW
# of Institutions
121Shares Held
19.7MCall Options Held
700KPut Options Held
575K-
Opaleye Management Inc. Boston, MA3.99MShares$181 Million21.35% of portfolio
-
Private Capital Management, LLC Naples, FL2.71MShares$123 Million7.1% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$97.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.84MShares$83.4 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA719KShares$32.6 Million0.0% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $1.23B
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...